Company overview
Basic information
Company name
Rytų Europos Egzistencinės terapijos asociacija
Company code
152841735
Registered address
Birštonas, Vilniaus g. 12-35, LT-59214
Registration date
2001-02-12
Company age: 25 y. 7 mo.
Contact information
Edit data
Phone
Email
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Association
NACE activity
Activities of business and employers membership organisations
Sector
Namų ūkiams paslaugas teikiančios ne pelno institucijos
Ownership form
Private without foreign capital
Beneficiary of support
Yes, since 2007-05-15
Rytų Europos Egzistencinės terapijos asociacija
Company code: 152841735
Address: Birštonas, Vilniaus g. 12-35, LT-59214
Download a detailed company report
Make confident decisions with all the information about Rytų Europos Egzistencinės terapijos asociacija. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.
Description
This description was generated by artificial intelligence.
Rytu Europos Egzistencines terapijos asociacija (company code 152841735) is an operational association registered on 2001-02-12. It is classified as a public, private-owned micro entity operating in the sector of non-profit institutions providing services to households, with governance described as a CEO with board/council. The company is based in Birštonas, Birštono municipality, Kaunas County, at Vilniaus g. 12-35, LT-59214. Its registered activity is under EVRK code T.94.11.00, covering activities of business and employers membership organisations. Financially, the association reported revenue of €12.6K in 2025, down from €24.9K in 2024, following €10.3K in 2023. It ended 2025 with a net loss of €493 and a profit margin of -3.9%. Equity stood at €30.7K, total assets at €34.8K and liabilities at €4.0K, leaving an equity ratio of 88.3% and debt to equity of 0.13. The business showed a return to loss in 2025 after a profitable 2024.